Ignite Creation Date:
2025-12-25 @ 3:37 AM
Ignite Modification Date:
2026-01-08 @ 2:44 PM
Study NCT ID:
NCT02423902
Status:
TERMINATED
Last Update Posted:
2025-08-28
First Post:
2015-04-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast Cancer
Sponsor:
Alaunos Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07-18
Start Date Type:
ACTUAL
Primary Completion Date:
2016-07-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-07-19
Completion Date Type:
ACTUAL
First Submit Date:
2015-04-06
First Submit QC Date:
None
Study First Post Date:
2015-04-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2025-03-25
Results First Submit QC Date:
None
Results First Post Date:
2025-08-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-10
Last Update Post Date:
2025-08-28
Last Update Post Date Type:
ESTIMATED